CT-1 is a novel orally bioavailable DNA minor groove ligand, against breast cancer by targeting tumor DNA damage leading to p53-dependent apoptosis. References: Messerli M, Ottilinger T, Warschkow R, Leschka S, Alkadhi H, Wildermuth S, Bauer RW. Emphysema quantification and lung volumetry in chest X-ray equivalent ultralow dose CT - Intra-individual comparison with standard dose CT. Eur J Radiol. 2017 Jun;91-9. doi: 10.1016/j.ejrad.2017.03.003. Epub 2017 Mar 14. PubMed PMID: 28629554.

纯度：≥98%

CAS：1983924-33-9